Global Health Technologies Coalition

Marissa Chmiola

Communications Officer

Marissa manages the development and implementation of the coalition’s communications strategies and activities. She oversees GHTC’s digital presence, media outreach, events, and publications.

Marissa has over a decade of experience working in communications and policy advocacy in Washington, DC. Prior to joining GHTC, she worked as a senior associate at the public policy firm of Manatos & Manatos where she addressed the communications, public policy, and event planning needs of clients in a variety of fields. Before that, she interned at several leading communications firms, including APCO Worldwide, West Wing Writers, and Hager Sharp.

Marissa received her BA in Public Communications and C.L.E.G. (Communications, Law, Economics, and Government) from American University in Washington, DC. In her free time, she enjoys playing soccer, traveling the world, and attempting to become a master chef.

Articles Written by Marissa

PATH/Gabe Bienczycki
A year in review: The global health innovation stories that shaped 2018

Two thousand eighteen was a turbulent year in global health. Between reemerging crises, breakthrough scientific discoveries, and the continued looming threat of health research funding cuts, 2018 took us on a roller coaster ride of peril and promise. Now as the year comes to an end, GHTC is taking a moment to reflect on the global health innovation stories and news that shaped 2018.

Read More
Flickr/macwagen
Play: TRICK or TREATment?

To enjoy a bit of fun and mischief this Halloween, we’ve created a new game, TRICK or TREATment, to test our readers’ knowledge of global health technologies.

Read More
UN Photo/Loey Felipe
Overheard at UNGA: 4 key takeaways on global health innovation

A “who’s who” of politicians, philanthropists, CEOs, and civil society leaders descended upon New York City this week for the annual United Nations General Assembly (UNGA). GHTC was there, serving as your eyes and ears on the ground. Here is what we heard and our top four takeaways on global health R&D.

Read More
Wanted: Tools to fight murderous mozzies and their deadly diseases

For World Mosquito Day, GHTC is taking a moment to shine a spotlight on the ghastly gang of mosquito-borne diseases and the innovations we need to finish these frightening foes for good.

Read More
PATH/Doune Porter
10 brilliant technological innovations to save moms and babies

For many mothers and babies around the world, the first 48 hours after birth are the most dangerous of their lives. For eight years, Saving Lives at Birth—spearheaded by USAID—has challenged problem solvers worldwide to create innovative solutions to make birth safer and save lives. Here are ten incredible innovations from this initiative:

Read More
Flickr/55thstreet
Global health and medical research saved from the chopping block in 2018 spending bill

What global health R&D advocates need to know about the 2018 omnibus spending bill.

Read More
PATH/Wendy Stone
Research Roundup: Discovering new antibiotics in soil and harnessing gene therapy to fight AIDS

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Sanofi Pasteur / Patrick Boulen
A year in review: The global health innovation stories that shaped 2017

As the year comes to an end, GHTC is reflecting on the top stories in global health innovation that made news in 2017.

Read More
Celebrating ten years of GHTC & a decade of progress in global health innovation

As we close out our 10th anniversary year, we wanted to take a moment to reflect on our shared progress and celebrate the headlines and moments that shaped global health R&D over the past decade. Check out some of the highlights...

Read More
Novartis
Research Roundup: A new anti-malarial, the promise of probiotics, and genetically-engineered TB

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
GHTC/Marissa Chmiola
A competition where the highest prize is lives saved

What do an onsite chlorine generator, fingerprint scanning technology for newborns, and temperature-monitoring wristband all have in common? The potential to save the lives of mothers and newborns in some of the poorest, hardest-to-reach communities around the world.

Read More
GHTC/Marissa Chmiola
Global health R&D gamified!

We ate, we drank, we played games, and we learned a thing or two about the impact of US leadership in global health R&D.

Read More
Devex
Meet GHTC’s new director, Jamie Bay Nishi

GHTC's new director Jamie Bay Nishi talks about her background, what inspires her, and her vision for the future of the coalition.

Read More
A cornucopia of thanks

In the spirit of the Thanksgiving holiday, GHTC asked our members and staff to share what they are most thankful for in global health.

Read More
CDC/Sue Partridge, CDC- Ft. Collins
Twenty six current and past ASTMH presidents call for Congress to act on Zika funding

Twenty six current and past presidents of the American Society of Tropical Medicine and Hygiene sent a letter urging Congress to pass an emergency spending bill to combat the Zika virus as soon as possible.

Read More
PATH/Evelyn Hockstein
Progress report on health R&D: A Q&A with USAID

USAID's Neal Brandes answers our questions about the agency's latest Health-Related Research and Development Progress Report and USAID's ongoing support for global health R&D.

Read More
Achim Hoerauf/Uniklinik Bonn
Research Roundup: Promising Zika drugs, micro-QR codes to fight counterfeit drugs, and a new antibiotic R&D accelerator

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Marissa Chmiola/GHTC
The potential, the pitch, and the prize: Innovators compete to save maternal and newborn lives

During the pitches at the Saving Lives at Birth DevelopmentXChange, the questions being asked were not how large the market, but how great the need, and not how much money can be made, but how many lives could be saved.

Read More
PATH, as secretariat of GHTC
Eight keys to success in building an effective coalition

We share our lessons learned in building a diverse, effective advocacy coalition for global health R&D.

Read More
PATH/Aaron Joel Santos
Celebrating over a decade of global health R&D advocacy

From humble origins to the premier advocacy organization focused on global health R&D. We tell the story of the birth of GHTC.

Read More
New affordable oral cholera vaccine receives WHO prequalification

In January, GHTC member International Vaccine Institute (IVI) announced that a new oral cholera vaccine it developed in partnership with Korean biotech company EuBiologics, Co. Ltd.—Euvichol®—received prequalification from the World Health Organization (WHO), paving the way for the vaccine to be purchased by global procurement bodies like Gavi, the Vaccine Alliance and UNICEF.

Read More
Harnessing health innovation to achieve the global goals

On January 1, the countdown to 2030 officially began with the implementation of the new global development goals.

Read More
GHTC/Marissa Chmiola
Celebrating US leadership in global health R&D on Capitol Hill

On Wednesday evening, GHTC was joined on Capitol Hill by congressional champions—Congressman Adam Smith (WA-9) and Congresswoman Betty McCollum (MN-4)—and global health community members for a reception celebrating US leadership in global health research and development (R&D) and the launch of the 2015 G-FINDER report, which tracks investment in neglected disease R&D.

Read More
What we’re thankful for in global health

It’s that time of year when Americans chow down on turkey with family and friends and express gratitude for the many things in life for which they are most thankful.

Read More
Rapid diagnostics needed to curb antibiotic resistance

New rapid diagnostics are urgently needed to prevent unnecessary use of antibiotics and curb the growing problem of antimicrobial resistance, according to a new report from the United Kingdom’s Review on Antimicrobial Resistance (AMR).

Read More
PATH/Jennifer Fox
Germany announces second PDP funding round: What’s different and how does it impact global health R&D

Earlier this month, Germany’s Federal Ministry of Education and Research (BMBF) the renewal of the German funding program for product development partnerships (PDPs) conducting research and development (R&D) for health technologies to combat poverty-related and neglected diseases (PRNDs).

Read More
GHTC
GHTC briefing highlights importance of health innovation to achieving global goals

With the Sustainable Development Goals (SDGs) freshly adopted, the Global Health Technologies Coalition (GHTC) gathered representatives from the private, public, and nonprofit sectors on Capitol Hill this past Wednesday to discuss what it will take to achieve the global goals.

Read More
PATH/Patrick McKern
Female condoms: the feel and shape of things to come

Take a stroll through any pharmacy and you’ll see shelves stacked with male condoms of many varieties, but look for a female condom and you aren't likely to find one for sale.

Read More
PATH/Eric Becker
Research Roundup: injectable HIV treatment, the role of health technologies in reaching SDGs, PrEP showing promise, and more

An injectable HIV/AIDS treatment that could offer HIV-positive individuals an option other than taking daily pills is entering late-stage clinical-trials.

Read More
When breastfeeding is not possible: How an innovative cup can save lives

Breast milk is the perfect first food for newborns; it provides nutrients and energy that infants need and contains substances that strengthen their immune systems.

Read More
New report on investment in R&D for HIV prevention highlights 2014 global funding trends

In this guest post, the HIV Vaccines & Microbicides Resource Tracking Working Group—comprised of AVAC as secretariat, the International AIDS Vaccine Initiative, and UNAIDS—discusses its new report examining investment in research and development (R&D) for HIV prevention options.

Read More
Entering the Shark Tank for maternal and newborn health innovation

Last Wednesday 53 teams of innovators gathered at the International Trade Center in Washington, DC, for the Saving Lives at Birth DevelopmentXChange—an event resembling a cross between a science fair and an episode of Shark Tank.

Read More
Architect of the Capitol
Celebrating America’s contributions to global health innovation

This Independence Day, GHTC is taking a break from our cookouts and parades to celebrate America’s extraordinary contributions to advancing innovation to save lives around the world.

Read More
21st Century Cures Act: What the global health community needs to know

Last week, the House Energy and Commerce Committee unanimously voted to approve the 21st Century Cures Act—a bill that aims to speed the development, approval, and introduction of new health technologies.

Read More
Mothers of innovation: Five mothers who have transformed global health

Breakthrough ideas are like children—they start small, they need constant nurturing, they don’t always develop according to schedule, but they change lives forever.

Read More
Seven takeaways on the post-2015 negotiations

Trying to navigate and understand the post-2015 negotiations can be a challenge, so to help add some clarity, last week the Global Health Technologies Coalition (GHTC) convened a panel of experts to help explain the ongoing debates and where the negotiations stand and how health innovation is reflected in the agenda.

Read More
Obama highlights global health and innovation in State of the Union address

While others were playing State of the Union bingo or creating pretty word clouds, GHTC was closely watching the State of the Union address to see what President Barack Obama would say about US engagement in global health and America’s leadership in science and innovation.

Read More
10 reasons why the US policymakers should support global health research and development

At the Global Health Technologies Coalition, our mission is to advance—through advocacy—the research and development (R&D) of new tools to prevent, diagnose, and treat global diseases.

Read More
CDC/James Gathaney
Research Roundup: R&D funding for neglected diseases, antimicrobial drug resistance, immunity for Ebola vaccine makers, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Aaron Joel Santos
Research Roundup: a weakened HIV virus, SDGs, powdered measles vaccine, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Doune Porter
Research Roundup: Gates Foundation open access policy, Ebola vaccine market, World AIDS Day, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Evelyn Hockstein
Research Roundup: Drug development costs, the price of priority review, new clinical trial requirements, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Ten global health advancements I’m thankful for this Thanksgiving

As global health advocates, our work often requires us to focus on unmet needs—such as the number of people worldwide who still die from preventable diseases each year, or the lack of adequate resources and investment to tackle these diseases.

Read More
PATH/Eric Becker
Research Roundup: Malaria eradication, indemnity for Ebola vaccine manufacturers, drug development impediments, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Research Roundup: Midterm elections, Ebola legislation, HIV prevention research, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Over 150 organizations and individuals urge UN to keep health R&D at the heart of the post-2015 agenda

With the 69th session of the United Nations (UN) General Assembly opening this week in New York and the global community debating how best to refine the post-2015 development agenda, over 150 organizations and individuals signed a petition to UN Secretary General Ban Ki-moon and Member States urging the UN to keep the research, development, and delivery of new and improved health tools at the heart of the post-2015 development agenda.

Read More
New TB drug bedaquiline: Weighing the benefits against the risks

Earlier this month, advocates from the Community Research Advisors Group (CRAG)—an international, community-based advisory body working to ensure the engagement of affected communities in tuberculosis (TB) research conducted by the Centers for Disease Control and Prevention (CDC) —published an article in The Lancet offering a community perspective on the use of the drug bedaquiline to treat drug-resistant and drug-susceptible TB.

Read More
Breastfeeding goes high tech

Breastfeeding has served as the primary method for a mother to feed her infant since the dawn of humanity, but could it also be a way for her to administer life-saving medicines to her baby?

Read More
Senate shows strong support for global health R&D in defense appropriations bill and report

Earlier this month, we reported that both the House and Senate Appropriations Committees included language supporting global health research and development (R&D) in their reports concerning funding for the Department of State, foreign operations and related programs.

Read More
Investing in global health innovation=smart power

During the past year, leaders from the US Global Leadership Coalition (USGLC)—an advocacy organization promoting diplomacy and development—have traveled across America seeking out innovators and innovations that best demonstrate how strategic US investments in global development can enhance America’s foreign policy and security interests—an approach USGLC calls “smart power” diplomacy.

Read More
How R&D is saving #momandbaby and helping children reach their #5thbday

Tomorrow US policymakers and global health advocates will come together to talk progress made on preventing maternal and child deaths.

Read More
PATH/Aaron Joel Santos
Could mapping the “human immunome” lead to the next generation of vaccines?

The answer is yes according to a group of 35 leading scientists who have come together to explore new strategies to accelerate vaccine development for deadly diseases such as malaria, HIV, tuberculosis (TB), and cancer.

Read More
PATH/Satvir Malhotra
CSIS panel: R&D fundamental to meeting new global TB targets

The development of new diagnostic, treatment, and prevention products is fundamental to accelerating the decline of the global tuberculosis (TB) burden, panelists from the World Health Organization (WHO), the National Institutes of Health (NIH), and the Bill & Melinda Gates Foundation agreed on during a panel discussion hosted by the Center for Strategic and International Studies (CSIS) on Monday.

Read More
PATH/Eric Becker
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Evelyn Hockstein
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Architect of the Capitol
Global health technology legislation introduced in Senate and what that means

The global health research community has a reason to celebrate this weekend. Yesterday, Senator Patty Murray (D-WA) introduced in the US Senate a significant piece of global health legislation that would strengthen global health research programming within the US Agency for International Development (USAID) and improve coordination of global health research and development (R&D) across the US government.

Read More
AVAC
Celebrating progress on World AIDS Vaccine Day

Yesterday, May 18, marked the observance of World AIDS Vaccine Day­­–an annual event to focus attention on the need for a vaccine to prevent HIV infection and AIDS.

Read More
Path/Mike Wang
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More

GHTC Team

 

Ansley Kahn

Senior Program Assistant

Learn More about Ansley

Emily Conron

Policy and Advocacy Officer

Learn More about Emily

Steering Committee

 

Rachel M. Cohen, MA

Regional Executive Director, North America

Drugs for Neglected Diseases initiative

Learn More about Rachel

Jodie Curtis

Washington Representative

American Society of Tropical Medicine and Hygiene

Learn More about Jodie

Kevin Fisher

Director of Policy, Data & Analytics

AVAC

Learn More about Kevin

Karen A. Goraleski, MA

Executive Director

American Society of Tropical Medicine and Hygiene

Learn More about Karen

Heather Ignatius, MA

Director, US and Global Advocacy

PATH

Learn More about Heather

Sharyn Tenn, MA

Senior Director, External Affairs and Product Access

International Partnership for Microbicides

Learn More about Sharyn